TerminatedEUCTR 2017-002232-16
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In United KingdomDepressionHistorical research record
- Countries
- United Kingdom
- Sponsor
- Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company, Ltd
CompletedEUCTR 2004-003781-14
Official study titleA Randomized, Double-Blind, Placebo-Controlled Study to Explore the Efficacy and Safety of Risperidone Long-Acting Intramuscular Injectable in the Prevention of Mood Episodes in Bipolar I Disorder,...
Original registry wording; source language not specified.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In AustriaBipolarityHistorical research record
- Countries
- Austria, Slovakia, Spain
- Sponsor
- Johnson & Johnson Pharmaceutical Research and Development
CompletedNCT05693935
What is this study about?Researchers compared TV-44749 and placebo to find out how the approaches affected psychotic symptoms in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including BentonvilleSchizophreniaMedication studyAges 18–64
- Countries
- United States, Bulgaria, China, + 2 others
- Sponsor
- Teva Branded Pharmaceutical Products R&D LLC
TerminatedNCT00997087
Official study titlePhase IIa A Randomized, Double-Blind, Placebo-Controlled Trial of Flumazenil for the Treatment of Obsessive Compulsive Disorder.
This study ended early.
In BirminghamOCDMedication studyAges 19–60
- Countries
- United States
- Sponsor
- Parkway Medical Center
CompletedEUCTR 2012-000418-13
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In United KingdomSchizophreniaHistorical research record
- Countries
- United Kingdom
- Sponsor
- AbbVie Deutschland GmbH & Co. KG
TerminatedEUCTR 2005-003475-20
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In Czech RepublicSchizophreniaHistorical research record
- Countries
- Czechia, Estonia
- Sponsor
- Solvay Pharmaceuticals, Inc
CompletedEUCTR 2015-005134-21
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In SlovakiaSchizophreniaHistorical research record
- Countries
- Slovakia
- Sponsor
- Noven Pharmaceuticals, Inc.
TerminatedEUCTR 2004-000114-40
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In AustriaBipolarityHistorical research record
- Countries
- Austria, Czechia, Slovakia
- Sponsor
- Novartis Pharma AG
CompletedEUCTR 2021-002068-30
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaSchizophreniaHistorical research record
- Countries
- Bulgaria, Poland
- Sponsor
- Intra-Cellular Therapies, Inc.
TerminatedEUCTR 2012-005000-17
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaOCDHistorical research record
- Countries
- United Kingdom, Bulgaria, Czechia, + 1 other
- Sponsor
- Novartis Pharma Services AG
CompletedEUCTR 2011-002048-29
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In RomaniaSchizophreniaHistorical research record
- Countries
- Romania, Slovakia
- Sponsor
- Forest Research Institute, Inc
CompletedEUCTR 2009-017271-17
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaSchizophreniaHistorical research record
- Countries
- Bulgaria
- Sponsor
- Janssen-Cilag International NV